Zobrazeno 1 - 10
of 287
pro vyhledávání: ''
Autor:
Michelle C. Williams, David E. Newby
Publikováno v:
Heart
Williams, M C & Newby, D E 2021, ' Prognostic value of fractional flow reserve from computed tomography ', Heart . https://doi.org/10.1136/heartjnl-2021-320375
Williams, M C & Newby, D E 2021, ' Prognostic value of fractional flow reserve from computed tomography ', Heart . https://doi.org/10.1136/heartjnl-2021-320375
Coronary artery disease remains the leading cause of death around the world, even during the COVID-19 pandemic, and it is therefore essential that we continue our quest to improve the prevention, diagnosis, management and outcome of coronary artery d
Autor:
Alastair J Moss, Gaurav S Gulsin
Publikováno v:
Heart (British Cardiac Society). 107(21)
Reducing the risk of plaque rupture events in individuals without a prior myocardial infarction is an imprecise science. To help clarify whether there is evidence of coronary artery disease and avoid ‘medicalisation’ of otherwise healthy individu
Publikováno v:
HEART
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Learning objectives #### Patients presenting with non-ST-segment elevation acute coronary syndrome (NSTEACS) #### Patients presenting with ST-segment elevation myocardial infarction (STEMI) #### Patients presenting with cardiogenic shock Acute corona
Autor:
David E. Newby, Alastair J Moss, Nick Spath, Marc R. Dweck, Lucy E Kershaw, Jayanth R. Arnold, Michelle C. Williams, Edwin J R van Beek, Thomas A Kite, Trisha Singh, Gerry P McCann, Shruti S Joshi, Gaurav S Gulsin, Scott Semple, Andy Baker, Helen Jordan
Publikováno v:
Singh, T, Kite, T A, Joshi, S S, Spath, N B, Kershaw, L, Baker, A, Jordan, H, Gulsin, G S, Williams, M C, Van Beek, E J R, Arnold, J R, Semple, S I K, Moss, A J, Newby, D E, Dweck, M & Mccann, G P 2021, ' MRI and CT coronary angiography in survivors of COVID-19 ', Heart, pp. heartjnl-2021-319926 . https://doi.org/10.1136/heartjnl-2021-319926
Heart
Heart
ObjectivesTo determine the contribution of comorbidities on the reported widespread myocardial abnormalities in patients with recent COVID-19.MethodsIn a prospective two-centre observational study, patients hospitalised with confirmed COVID-19 underw
Autor:
Rong Bing, Trisha Singh
Publikováno v:
Heart (British Cardiac Society).
In an era of incremental gains in preventative cardiology, the ongoing pursuit of reduction in ischaemic events has led to advances in the antiplatelet armamentarium that is available for use after percutaneous coronary intervention (PCI). The protec
Autor:
Emanuele Barbato
Publikováno v:
Heart (British Cardiac Society). 107(18)
Learning objectives Management of patients with calcified coronary lesions represents one of the last unmet clinical needs in interventional cardiology. The age of patients referred for invasive coronary angiography with indication to revascularisati
Autor:
Daniele Massera, John S. Gottdiener, Jorge R. Kizer, Sanjiv J. Shah, Traci M. Bartz, Stephen J Dvorak, Joseph A.C. Delaney, Christopher DeFilippi, Megan E Bach, Bruce M. Psaty, Mo Hu
Publikováno v:
Heart
ObjectivesSpeckle-tracking echocardiography enables detection of abnormalities in cardiac mechanics with higher sensitivity than conventional measures of left ventricular (LV) dysfunction and may provide insight into the pathogenesis of coronary hear
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
Publikováno v:
Heart (British Cardiac Society). 108(1)
Sodium glucose cotransporter 2 inhibitors (SGLT2i) have emerged as a class of medications with positive cardiovascular (CV) effects across a spectrum of patients with and without type 2 diabetes (T2D). In heart failure with reduced ejection fraction,
Autor:
Kathleen W. Zhang
Publikováno v:
Heart (British Cardiac Society). 107(8)
Imatinib was introduced on the cover of TIME magazine in 2001 as ‘the magic bullet’ to cure cancer, ushering in a new era of targeted cancer therapeutics that has transformed the modern landscape of cancer treatment. As the first tyrosine kinase
Autor:
Jonathon Leipsic, Abdul Rahman Ihdayhid, Damini Dey, Alexander Chua, Brian Ko, Timothy A. Fairbairn, Daniel Adams, Ron Blankstein
Publikováno v:
Heart (British Cardiac Society). 108(4)
Epidemiological studies have observed East Asians (EAs) are significantly less likely to develop or die from coronary artery disease (CAD) compared with Caucasians. Conversely South Asians (SAs) develop CAD at higher rate and earlier age. Recently, a